CX3CL1 and Stroke: We reanalyzed plasma IL-1β, IL-6, TNF-α, sICAM-1, sVCAM-1, and FKN levels data obtained in a previous study [17] to test potential differences between HGS stroke patients (within 7 days or 1-year from stroke onset) and healthy controls (Fig. 5).